The impact of anti-tuberculous antibiotics and corticosteroids on cytokine production in QuantiFERON-TB Gold In Tube assays

Tuberculosis

Volumn 95, Issue 3, 2015, Pages 343-349

  Clifford, Vanessa ^a   Zufferey, Christel ^a   Germano, Susie ^a   Ryan, Norbert ^b   Leslie, David ^b   Street, Alan ^c   Denholm, Justin ^c   Tebruegge, Marc ^a,d   Curtis, Nigel ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b VICTORIAN INFECTIOUS DISEASES REFERENCE LABORATORY   (Australia)

^c ROYAL MELBOURNE HOSPITAL   (Australia)

^d UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

Antibiotics; Cytokines; Diagnosis; Immunomodulation; Mycobacterium tuberculosis; QuantiFERON TB Gold; Tuberculosis

Indexed keywords

CIPROFLOXACIN; CYTOKINE; DEXAMETHASONE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 2; ISONIAZID; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; RIFAMPICIN; TUBERCULOSTATIC AGENT; TUMOR NECROSIS FACTOR ALPHA; BIOLOGICAL MARKER; CORTICOSTEROID; GAMMA INTERFERON; IFNG PROTEIN, HUMAN;

ADULT; ARTICLE; CLINICAL ARTICLE; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; DRUG BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HOST; HUMAN; IMMUNOMODULATION; LATENT TUBERCULOSIS; MALE; MYCOBACTERIUM TUBERCULOSIS TEST KIT; PRIORITY JOURNAL; SUPERNATANT; BLOOD; IMMUNOLOGY; INTERFERON GAMMA RELEASE ASSAY; MICROBIOLOGY; PREDICTIVE VALUE; REPRODUCIBILITY; YOUNG ADULT;

ADRENAL CORTEX HORMONES; ADULT; ANTIBIOTICS, ANTITUBERCULAR; BIOMARKERS; CYTOKINES; DEXAMETHASONE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INTERFERON-GAMMA; INTERFERON-GAMMA RELEASE TESTS; LATENT TUBERCULOSIS; MALE; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; YOUNG ADULT;

EID: 84929293210     PISSN: 14729792     EISSN: 1873281X     Source Type: Journal    
DOI: 10.1016/j.tube.2015.02.039     Document Type: Article

References (33)

1. E. Chiappini, F. Bonsignori, G. Accetta, V. Boddi, L. Galli, and A. Biggeri Interferon-release assays for the diagnosis of Mycobacterium tuberculosis infection in children: a literature review Int J Immunopath Pharmacol 25 2012 335 343
2. T.G. Connell, M.A. Davies, C. Johannisen, K. Wood, S. Pienaar, and K.A. Wilkinson Reversion and conversion of Mycobacterium tuberculosis IFN-gamma ELISpot results during anti-tuberculous treatment in HIV-infected children BMC Infect Dis 10 2010 138
3. M.T. Labro Interference of antibacterial agents with phagocyte functions: immunomodulation or "immuno-fairy tales"? Clin Microbiol Rev 13 2000 615 650
4. M. Shinkai, M.O. Henke, and B.K. Rubin Macrolide antibiotics as immunomodulatory medications: proposed mechanisms of action Pharmacol Ther 117 2008 393 405
5. H.M. Ziglam, I. Daniels, and R.G. Finch Immunomodulating activity of rifampicin J Chemother 16 2004 357 361
6. V.A. Serebriakova, O.A. Vasil'eva, O.I. Urazova, V.V. Novitskii, O.V. Voronkova, and A.K. Strelis Modulatory effect of isoniazid and rifampicin in vitro on cytokine secretion in pulmonary tuberculosis Probl Tuberk Bolezn Legk 2009 58 65
7. E.J. Kucharz Studies on immunomodulatory properties of isoniazid. Influence of isoniazid on responsiveness of peripheral blood mononuclear cells to interleukin-2 Cent Eur J Public Health 3 1995 65 66
8. E.J. Kucharz, and S.J. Sierakowski Studies on immunomodulatory properties of isoniazid. II. Effect of isoniazid on interleukin 2 production and interleukin 2-receptor expression J Hyg Epidemiol Microbiol Immunol 34 1990 207 211
9. E.J. Kucharz, and S.J. Sierakowski Studies on immunomodulatory properties of isoniazid: V. Influence of isoniazid on secretion of interleukin-1 J Hyg Epidemiol Microbiol Immunol 36 1992 119 122
10. N. An, Y. Song, X. Zhang, X. Ci, H. Li, and Y. Cao Pretreatment of mice with rifampicin prolongs survival of endotoxic shock by modulating the levels of inflammatory cytokines Immunopharmacol Immunotoxicol 30 2008 437 446
11. U. Krehmeier, M. Bardenheuer, G. Voggenreiter, U. Obertacke, F.U. Schade, and M. Majetschak Effects of antimicrobial agents on spontaneous and endotoxin-induced cytokine release of human peripheral blood mononuclear cells J Infect Chemother 8 2002 194 197
12. S.-Y. Eum, Y.-J. Lee, J.-H. Min, H.-K. Kwak, M.-S. Hong, and J.-H. Kong Association of antigen-stimulated release of tumor necrosis factor-alpha in whole blood with response to chemotherapy in patients with pulmonary multidrug-resistant tuberculosis Respiration 80 2010 275 284
13. V.H. Sai Priya, B. Anuradha, S. Latha Gaddam, S.E. Hasnain, K.J.R. Murthy, and V.L. Valluri In vitro levels of interleukin 10 (IL-10) and IL-12 in response to a recombinant 32-kilodalton antigen of Mycobacterium bovis BCG after treatment for tuberculosis Clin Vaccine Immunol 16 2009 111 115
14. S. Bihari, N. Cavalcanti, J.B. Correia, G. Alves, E. Souza, and B.J. Brabin Interferon gamma-induced protein-10 concentrations in children with previous tuberculosis infections and disease Pediatr Infect Dis J 31 2012 1089 1091
15. M. Tebruegge, N. Ritz, T. Connell, and N. Curtis A 2 year old girl with fever, cough, and tachypnoea BMJ 338 2009 b1210
16. E. Belard, S. Semb, M. Ruhwald, A.M. Werlinrud, B. Soborg, and F.K. Jensen Prednisolone treatment affects the performance of the QuantiFERON gold in-tube test and the tuberculin skin test in patients with autoimmune disorders screened for latent tuberculosis infection Inflamm Bowel Dis 17 2011 2340 2349
17. J. Keane, S. Gershon, R.P. Wise, E. Mirabile-Levens, J. Kasznica, and W.D. Schwieterman Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent N Engl J Med 345 2001 1098 1104
18. P. Brassard, A. Kezouh, and S. Suissa Antirheumatic drugs and the risk of tuberculosis Clin Infect Dis 43 2006 717 722
19. Cellestis QuantiFERON-TB Gold (In-Tube method): the whole blood IFN-gamma test measuring responses to ESAT-6, CFP-10 & TB7.7 peptide antigens. Package insert 2006 Cellestis Ltd Carnegie, Australia
20. S.K. Heysell, J.L. Moore, S.J. Keller, and E.R. Houpt Therapeutic drug monitoring for slow response to tuberculosis treatment in a state control program, Virginia, USA Emerg Infect Dis 16 2010 1546 1553
21. M.A. Gonzalez, F. Uribe, S.D. Moisen, A.P. Fuster, A. Selen, and P.G. Welling Multiple-dose pharmacokinetics and safety of ciprofloxacin in normal volunteers Antimicrob Agents Chemother 26 1984 741 744
22. O. Weijtens, R.C. Schoemaker, A.F. Cohen, F.P. Romijn, E.G. Lentjes, and J. van Rooij Dexamethasone concentration in vitreous and serum after oral administration Am J Ophthalmol 125 1998 673 679
23. I. Sauzullo, F. Mengoni, M. Lichtner, A.P. Massetti, R. Rossi, and M. Iannetta In vivo and in vitro effects of antituberculosis treatment on mycobacterial interferon-gamma T cell response PLoS One 4 2009 e5187
24. I. Sauzullo, F. Mengoni, A. Ermocida, A.P. Massetti, C. D'Agostino, and G. Russo Interferon-gamma release assay in HIV-infected patients with active tuberculosis: impact of antituberculous drugs on host immune response New Microbiol 37 2014 153 161
25. K.A. Wilkinson, O.M. Kon, S.M. Newton, G. Meintjes, R.N. Davidson, and G. Pasvol Effect of treatment of latent tuberculosis infection on the T cell response to Mycobacterium tuberculosis antigens J Infect Dis 193 2006 354 359
26. M. Ruhwald, M. Bjerregaard-Andersen, P. Rabna, J. Eugen-Olsen, and P. Ravn IP-10, MCP-1, MCP-2, MCP-3, and IL-1RA hold promise as biomarkers for infection with M. tuberculosis in a whole blood based T-cell assay BMC Res Notes 2 2009 19
27. M. Frahm, N.D. Goswami, K. Owzar, E. Hecker, A. Mosher, and E. Cadogan Discriminating between latent and active tuberculosis with multiple biomarker responses Tuberculosis 91 2011 250 256
28. J. Lighter-Fisher, C.H. Peng, and D.B. Tse Cytokine responses to QuantiFERON peptides, purified protein derivative and recombinant ESAT-6 in children with tuberculosis Int J Tuberc Lung Dis 14 2010 1548 1555
29. M. Ruhwald, M.G. Aabye, and P. Ravn IP-10 release assays in the diagnosis of tuberculosis infection: current status and future directions Exp Rev Mol Diagn 12 2012 175 187
30. D.Y. Chen, G.H. Shen, Y.M. Chen, H.H. Chen, C.C. Lin, and C.W. Hsieh Interferon-inducible protein-10 as a marker to detect latent and active tuberculosis in rheumatoid arthritis Int J Tuberc Lung Dis 15 2011 192 200
31. M. Armand, V. Chhor, A. de Lauzanne, V. Guerin-El Khourouj, B. Pedron, and M. Jeljeli Cytokine responses to quantiferon peptides in pediatric tuberculosis: a pilot study J Infect 2014 Jan;68(1):62-70
32. N. Alsleben, M. Ruhwald, H. Russmann, F.M. Marx, U. Wahn, and K. Magdorf Interferon-gamma inducible protein 10 as a biomarker for active tuberculosis and latent tuberculosis infection in children: a case-control study Scand J Infect Dis 44 2012 256 262
33. V. Clifford, C. Zufferey, A. Street, J. Denholm, M. Tebruegge, and N. Curtis Cytokines for monitoring anti-tuberculous therapy: A systematic review Tuberculosis 2015 10.1016/j.tube.2015.01.003